Molecular Diagnostics

Mindray Launches High-Sensitivity and High-Specificity ToRCH Panel
Mindray (Shenzhen, China) has launched the ToRCH Panel that provides high-quality assays to meet different clinical needs. Thanks to the improved raw materials, processes, formulas, reaction models, and standardized traceability, Mindray ToRCH reagents deliver excellent seroconversion sensitivity. More...28 Sep 2022

Single Blood Test Predicts Risk of Multiple Diseases Simultaneously Using AI
Scientists have profiled 168 metabolic markers in the blood samples of over 100,000 people and combined this data with their medical histories. Using AI, they were able to predict the risk of onset of several diseases with just one test and show where early intervention could be beneficial. More...26 Sep 2022

Simple Blood Test Prior to CAR T-Cell Therapy Could ID Patients at Risk for Neurotoxicity
Neurologic complications are common following treatment with chimeric antigen receptor (CAR) T cells. Now, a small study has demonstrated that a simple blood test before treatment can help identify patients who may be more likely to develop neurotoxicity. More...23 Sep 2022

A Single-Cell RNA-Sequencing-Based Non-Invasive Screening Tool for Endometriosis
Results presented in a recent paper lay the ground work for using menstrual effluent (ME) as an effective screening tool for identifying endometriosis in patients with chronic symptoms suggestive of this disorder. More...21 Sep 2022

Bioperfectus Launches New MPXV Detection Kits for Better Control of Monkeypox Virus Outbreak
Since January 2022, cases of monkeypox have been reported across almost 60,000 in 102 countries and regions. In order to assist in efforts to control the monkeypox outbreak, Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) has launched four new PCR products. More...21 Sep 2022

New Diagnostic Tool Reads Fracture Risk in Drop of Blood
A new device diagnoses bone fragility based on a novel approach via blood sampling. This test is much more specific than current techniques and will significantly improve diagnosis and advance the development of new treatments for osteoporosis. More...21 Sep 2022

Simple Blood and Urine Test Can Help Patients with Chronic Kidney Disease
A simple blood and urine test can identify those most at risk of severe complications of chronic kidney disease. However, many patients and physicians remain unaware of the test’s life-saving potential, according to a new study. More...21 Sep 2022
In Other News
New Biomarkers to Help Gauge Response of Melanoma Patients to Immune Checkpoint Therapy
Ultima Genomics Sequencer for Single-Cell RNA-Seq Evaluated
AI-Enabled POC Device Detects Cancers Without Biopsies
Endotrophin Blood Test Can Predict Outcomes in Patients with Heart Failure
Inherited Genetic Variants Increase Risk of Hodgkin Lymphoma
Molecular Endometrial Cancer Test Developed
Portable Sample-to-Answer PCR System Enables Multiplex Real-Time Detection of 27 Targets
Simple Blood Test Can Detect Early-Stage Colorectal Cancer from Gut Bacteria
Simple Blood Test Quickly and Accurately Detects Ovarian Cancer
Blood-Based Liver Disease Test Could Replace Invasive Biopsy
MCED Tests Mark New Era of Early Cancer Detection
Metabolic Disturbances Characterize Patients with Idiopathic Intracranial Hypertension
Multiparameter Test Could Detect and Diagnose Cancer from a Milliliter of Blood
Portable, Sample to Answer PCR Device Delivers Accurate Results in 30 Minutes at Point of Need
Rapid POC Diagnostic Test for Syphilis Could Produce Results in Under 20 Minutes
African-Specific Molecular Taxonomy of Prostate Cancer Revealed
Elevated Blood Levels of Neurofilament Light Chain Predict Likelihood of Neurotoxicity Following CAR-T Immunotherapy
qPCR Assay Identifies Melanoma Patients With Low-Risk Tumor That Could Avoid Invasive Biopsy
Improved ALS Blood Test Requires Less Stringent Storage and Work Conditions
AI Algorithm Combined With Blood Test Quickly and Accurately Diagnoses Heart Attacks in Women
EV-based Liquid Biopsy for the Diagnosis of Early-Stage Liver Cancer
Fast, Accurate and Portable Molecular Analyzer to Revolutionize Diagnostics
First-of-Its-Kind Blood Test Evaluates Severity and Predicts Survivability in Rare Lung Disease
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.